Stocktoria

Clearside Biomedical, Inc. CLSDQ

OTC · stock · Pharmaceutical Preparations · website · IPO 2016-06-02 · LEI

Clearside Biomedical, Inc. statistics & valuation

Market cap$580,000
P / S0.3×
Net margin-2064.4%
FCF margin-1543.0%
Return on capital-142.1%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-4977.30% -17094.20% -276060.00% -1416.00% -230.70% 1.30% -2482.80% -394.90% -2064.40% 2016201720172018201920202021202220232024
Gross margin (%)
2016201720172018201920202021202220232024
Operating margin (%)
-4845.80% -16929.90% -276483.30% -1394.60% -227.20% -2.10% -2281.60% -302.00% -1735.70% 2016201720172018201920202021202220232024
Return on equity (%)
-36.10% -275.40% -350.60% -275.80% -207.80% 1.00% -310.60% 2016201720172018201920202021202220232024
Shares outstanding
24.6M 25.3M 25.4M 32.1M 44.4M 51.9M 59.9M 60.6M 62.9M 73.8M 2016201720172018201920202021202220232024
Net debt ($)
-$26.8M -$15.0M -$1.2M $2.0M -$17.6M 2016201720172018201920202021202220232024
Share buybacks ($)
2016201720172018201920202021202220232024
Return on assets (%)
-30.50% -145.60% -187.70% -114.90% -94.20% 0.90% -64.20% -95.50% -136.70% 2016201720172018201920202021202220232024
Free cash flow margin (%)
-4367.70% -14895.40% -264293.30% -1246.80% -166.90% -36.30% -1025.70% -242.10% -1543.00% 2016201720172018201920202021202220232024
Debt / equity (×)
0.11× 0.12× 0.37× 0.42× 0.45× 2016201720172018201920202021202220232024
EPS ($)
-$0.81 -$0.39 $0.01 -$0.55 -$0.53 -$0.47 2016201720172018201920202021202220232024

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Operating margin-1735.7%-302.0%-2281.6%-2.1%-227.2%-1394.6%-276483.3%-16929.9%—-4845.8%
Net margin-2064.4%-394.9%-2482.8%1.3%-230.7%-1416.0%-276060.0%-17094.2%—-4977.3%
FCF margin-1543.0%-242.1%-1025.7%-36.3%-166.9%-1246.8%-264293.3%-14895.4%—-4367.7%
Return on assets-136.7%-95.5%-64.2%0.9%-94.2%-114.9%-187.7%-145.6%—-30.5%
Return on equity88.4%204.2%-310.6%1.0%-207.8%-275.8%-350.6%-275.4%—-36.1%
Debt / equity—————0.45×0.42×0.37×0.12×0.11×
Current ratio4.444.428.549.081.822.314.102.9011.2015.59

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.